Cardiac dysfunction in cancer patients : beyond direct cardiomyocyte damage of anticancer drugs. Novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart
| dc.contributor.author | Tocchetti, Carlo G | |
| dc.contributor.author | Ameri, Pietro | |
| dc.contributor.author | de Boer, Rudolf A | |
| dc.contributor.author | D'Alessandra, Yuri | |
| dc.contributor.author | Russo, Michele | |
| dc.contributor.author | Sorriento, Daniela | |
| dc.contributor.author | Ciccarelli, Michele | |
| dc.contributor.author | Kiss, Bernadett | |
| dc.contributor.author | Bertrand, Luc | |
| dc.contributor.author | Dawson, Dana | |
| dc.contributor.author | Falcao-Pires, Ines | |
| dc.contributor.author | Giacca, Mauro | |
| dc.contributor.author | Hamdani, Nazha | |
| dc.contributor.author | Linke, Wolfgang A | |
| dc.contributor.author | Mayr, Manuel | |
| dc.contributor.author | van der Velden, Jolanda | |
| dc.contributor.author | Zacchigna, Serena | |
| dc.contributor.author | Ghigo, Alessandra | |
| dc.contributor.author | Hirsch, Emilio | |
| dc.contributor.author | Lyon, Alexander R | |
| dc.contributor.author | Görbe, Anikó | |
| dc.contributor.author | Ferdinandy, Péter | |
| dc.contributor.author | Madonna, Rosalinda | |
| dc.contributor.author | Heymans, Stephane | |
| dc.contributor.author | Thum, Thomas | |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Medical Sciences - Cardiovascular Group | en |
| dc.date.accessioned | 2021-07-18T23:08:10Z | |
| dc.date.available | 2021-07-18T23:08:10Z | |
| dc.date.issued | 2020-09-01 | |
| dc.description | Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions please email: journals.permissions@oup.com. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 14 | |
| dc.format.extent | 1172768 | |
| dc.identifier | 173802935 | |
| dc.identifier | 41a65830-fa46-4c43-9c4e-a167e9d41d08 | |
| dc.identifier | 32683451 | |
| dc.identifier | 85088271730 | |
| dc.identifier | 000569698900012 | |
| dc.identifier.citation | Tocchetti, C G, Ameri, P, de Boer, R A, D'Alessandra, Y, Russo, M, Sorriento, D, Ciccarelli, M, Kiss, B, Bertrand, L, Dawson, D, Falcao-Pires, I, Giacca, M, Hamdani, N, Linke, W A, Mayr, M, van der Velden, J, Zacchigna, S, Ghigo, A, Hirsch, E, Lyon, A R, Görbe, A, Ferdinandy, P, Madonna, R, Heymans, S & Thum, T 2020, 'Cardiac dysfunction in cancer patients : beyond direct cardiomyocyte damage of anticancer drugs. Novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart', Cardiovascular Research, vol. 116, no. 11, pp. 1820-1834. https://doi.org/10.1093/cvr/cvaa222 | en |
| dc.identifier.doi | 10.1093/cvr/cvaa222 | |
| dc.identifier.iss | 11 | en |
| dc.identifier.issn | 0008-6363 | |
| dc.identifier.other | ORCID: /0000-0003-2815-4469/work/160846653 | |
| dc.identifier.uri | https://hdl.handle.net/2164/16833 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85088271730&partnerID=8YFLogxK | en |
| dc.identifier.vol | 116 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Cardiovascular Research | en |
| dc.subject | SDG 3 - Good Health and Well-being | en |
| dc.subject | Cardio-Oncology | en |
| dc.subject | Common pathways in heart failure and cancer | en |
| dc.subject | Multicellular an multiorgan mechanisms | en |
| dc.subject | Multicellular and multiorgan mechanisms | en |
| dc.subject | DOXORUBICIN-INDUCED CARDIOTOXICITY | en |
| dc.subject | IMMUNE CHECKPOINT INHIBITORS | en |
| dc.subject | INFLAMMATORY RESPONSES | en |
| dc.subject | PRESERVED EJECTION FRACTION | en |
| dc.subject | EUROPEAN-SOCIETY | en |
| dc.subject | LUNG-CANCER | en |
| dc.subject | CHAIN FATTY-ACIDS | en |
| dc.subject | CLONAL HEMATOPOIESIS | en |
| dc.subject | CARDIOVASCULAR-DISEASE | en |
| dc.subject | HISTONE DEACETYLASE | en |
| dc.subject | Multicellular | en |
| dc.subject | Multiorgan mechanisms | en |
| dc.subject | R Medicine | en |
| dc.subject | Cardiology and Cardiovascular Medicine | en |
| dc.subject | Physiology (medical) | en |
| dc.subject | Physiology | en |
| dc.subject.lcc | R | en |
| dc.title | Cardiac dysfunction in cancer patients : beyond direct cardiomyocyte damage of anticancer drugs. Novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Tocchetti_cvaa_Cardiac_dysfunction_AAM.pdf
- Size:
- 1.12 MB
- Format:
- Adobe Portable Document Format
